CanniMed Therapeutics Inc.


Company Description:

CanniMed is a Canadian-based, international plant biopharmaceutical company and leader in the Canadian medical cannabis industry, with 15 years’ of pharmaceutical cannabis cultivation experience, state-of-the-art, a GMP-compliant production process, including 281 points of quality control and world class research and development platforms with a wide range of pharmaceutical-grade cannabis products.

The Company also has an active plant biotechnology research and product development program focused on the production of plant-based materials for pharmaceutical, agricultural and environmental applications.

Latest News & Stories on CanniMed Therapeutics Inc. (TSX:CMED) (OTC:CMMDF) (FRA:0GB)